Subscribe to:
Post Comments (Atom)
skip to main |
skip to left sidebar
skip to right sidebar
Long Term Wealth Creation in Indian Financial Market
Labels
- 001-Wealth Creation-Bonds (5)
- 001-Wealth Creation-Equity (1)
- Bartronics India Ltd (1)
- Bilcare Ltd (1)
- Biocon Ltd (1)
- Blue Star Ltd (2)
- Confidence Petroleum Ltd (2)
- Geodesic Ltd (2)
- Glenmark Pharma (1)
- ICSA India Ltd (2)
- Ion Exchange India Ltd (2)
- Jetking Infotrain Ltd (1)
- Karuturi Global Ltd (1)
- Micro Technologies Ltd (6)
- Opto Circuits Ltd (1)
- Royal Orchid Hotels (1)
- Sayaji Hotels Ltd (1)
- Shanthi Gears Ltd (2)
- Sical Logistics Ltd (2)
- SREI Infrastructure Ltd (2)
- Time Technoplast Ltd (4)
- Zen Technologies Ltd (1)
|
| Subscribe to smart-indian |
| Visit this group |
Search This Blog
Market Psychology
Reader Comments
Company Announcements
- Bartonics India Ltd
- Bilcare Ltd
- Blue Star Ltd
- Confidence Petroleum Ltd
- Everonn Education Ltd
- Geodesic Ltd
- ICSA India Ltd
- Jetking Infotrain Ltd
- Karuturi Ltd
- Micro Technologies Ltd
- Opto Circuits Ltd
- PVR Ltd
- Praj Industries Ltd
- Punj Lloyd Ltd
- Rolta India Ltd
- Royal Orchid Hotels
- Sayaji Hotels Ltd
- Shanthi Gears Ltd
- Sical Logistics Ltd
- SREI Infrastructure Ltd
- Suzlon Ltd
- Time Technoplast
- Unitech Ltd
- Yes Bank
- Zen Technologies
Disclaimer
This blog site is subject to change without prior notice. All the information in this site are from sources which are believed to be reliable and are from public domain. While my endeavor would to keep the information up to date in this site, I am under no obligation to do so. All the recommendations in the site are my viewpoints only. Users are expected to do a complete due diligence before acting on them and they assume the entire risk and reward of any such action.
3 comments:
Packaging solutions provider Bilcare Ltd today launched its anti-counterfeit technology for the Indian automobile industry, which has been dealing with spurious components for long.
"Counterfeit components are not only a threat to the profit of automobile manufacturers but also to the vehicle users using sub-standard safety and performance parts. Our technology, equipped with nanotechnology and bluetooth, will fight this problem of the industry," Bilcare Technologies President and CEO Raman Nanda told PTI.
While launching the technology at the Society of Indian Automobile Manufacturers (SIAM) Annual Convention here, he said various car parts in India constitute an estimated 37 per cent of the total components market.
The company has launched the product from its Singapore facility, where it had earlier committed Rs 100 crore investment for carrying out R&D and setting up the plant.
When asked about the sales target in India, Nanda said: "In the next five to seven years we have a global target of up to one billion dollar from all industries, like automobile, engineering, fashion, pharma and aviation. Of this, India's share will be about 15-20 per cent."
Bilcare is also talking to some IT firms for forming alliances and partnerships in India, he said, but declined to give details.
According to a survey conducted by Motor & Equipment Manufacturers Association (MEMA), the global automotive industry loses up to 12 billion dollar per year to counterfeiting.
Bilcare Global Clinical Supplies expands India facility
Bilcare Global Clinical Supplies (GCS), a leading multi regional provider of clinical trial materials (CTM) services, under its global expansion program, has significantly expanded its packaging operations and Storage capacities at its Pune, India facility to further strengthen its offering to its global customers.
With the current expansion in the facility at Pune, India, the packaging and storage capabilities have increased multifold and the facility has now the ability to manufacture, package and distribute CTM using its own in-house IVRS. The facility with its approval from the local FDA as well as the Narcotics Control Bureau is now fully equipped to not only manage normal CTM but also controlled drug substances.
The facility at Pune, India was commissioned in October 2005 making it the first major operation for providing CTM in India. Subsequently, Bilcare GCS made rapid strides in establishing and continually expanding its operational and distribution capabilities across the world with prime focus on its facilities in Pennsylvania, USA and Powys, UK where it recently infused a major expansion and technology up-gradation program. Bilcare GCS also significantly strengthened its distribution capabilities across the world with its recent formal working agreement with World Courier, a leading specialty logistics company with cold chain expertise.
Mohan Bhandari, Chairman & Managing Director, Bilcare Limited said, the significant investments into the GCS operations and facilities across the world is a testimony to Bilcare’s commitment of bringing immense value to its customers by way of realizing its motto of “Speed to Market”. The strategic Global presence & focused offerings, along with unique project management skills and collaborative approach form the tenets of key value to our customers. In these times of ever increasing complexities and cost, our innovative offerings are providing synergistic impetus to the pharma innovators who are seeking supportive innovations for enhancing their untiring efforts to bring out newer and safer life saving drugs”.
In the recent past, Bilcare GCS USA facility has expanded its operational capabilities with 26 state-of- the-art packaging rooms, new high-speed blistering technology and large-scale bottling line and tripled its capacity of ambient storage facility. The USA facility has also expanded pre-clinical and early-stage development capabilities to include upgraded granulation and capsule filling technology along with significantly enhanced capacity of its formulation and analytical development services. Similar packaging technology up-gradation were done at the UK facility. Bilcare GCS also strengthened its distribution reach in Argentina, Brazil, Columbia, Chile, Mexico, Peru, Russia and Eastern Europe apart from its own facilities by entering into a formal working agreement with World Courier.
“Bilcare GCS continually strives to meet the market demand and has undertaken operations modernization & technology up-gradation of its facilities in USA and UK and now in India. This will significantly enhance the capability of sponsors to conduct clinical trails across the world inclusive of Asia with desired alacrity”, says Ajit Dubhashi – President, Bilcare GCS, Asia Pacific.
Bilcare starts Certificate Program in Clinical Research
Bilcare Research Academy is set to commence a specially designed new short duration ‘Certificate Program in Clinical Research’ for working professionals. Admissions are now open at Bilcare Research Academy, Bengaluru and the course commences from February 2009.
The Certificate Program in Clinical Research (CPCR) is six months weekend program designed with a vision to create competent Clinical Research Professionals. Spread over 24 weekends, of duration four hours a day on Saturdays and Sundays, the course offers flexibility to participants, while the content will be comprehensive and detailed. At the end of the program, participants will receive Certificates from ‘Bilcare Research Academy’, which holds immense value and significant recognition in the Clinical Research Organisations, Pharmaceutical industries and Biotechnology industries.
source: moneycontrol
-manish
Post a Comment